Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Interleukin-2 Effectiveness?

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
1,945
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 14, 2009

Cliff Lane, National Institutes of Health, discusses the most recent studies in the use of Interleukin-2 in boosting CD-4+ cells and the clinical outcomes for people with HIV.
He also explains the differences between the innate an adaptive immune systems.

Interviewed at the 16th Conference on Retroviruses and Opportunistic Infections, Montreal, February 2009.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (2)

Sign In or Sign Up now to post a comment!
  • i still see studies that have come out after that show increased response to IL2 in certain cancers (this focuses on HIV)....but still an overall low response rate less than or around 20%

  • good video....first comment*****

Loading...
Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more